Marksans Pharma Limited has submitted a regulatory filing to the BSE Limited and the National Stock Exchange of India Limited intimating them of a special window for the re-lodgment of physical share transfer requests. This action is in compliance with a directive from the Securities and Exchange Board of India (SEBI).

Key Details of the Special Window

  • Purpose: To facilitate the re-lodgment of transfer deeds for shares that were purchased or sold prior to April 1, 2019 but were subsequently rejected, returned, or not attended to due to deficiencies in the transfer documents or other reasons.
  • Window Period: The special window is open for one year, from February 5, 2026, to February 4, 2027.

Process and Conditions for Transferees

  • Transferees must re-lodge the original transfer deeds along with the share certificates, complete in all respects.
  • If the documents are found in order, the transfer will be registered, and the shares will be credited only in demat mode; no physical share certificates will be issued.
  • Shares successfully transferred under this window will be under a lock-in for a period of one year from the date of registration of the transfer. During this lock-in period, the shares cannot be transferred, lien-marked, or pledged.

Mandatory Document Requirements

Transferees are mandatorily required to submit the following documents:

  • a. Original share certificate
  • b. Transfer deed executed prior to April 1, 2019
  • c. Proof of purchase by transferee
  • d. KYC documents of the transferee (as per ISR forms)
  • e. Latest Client Master List of the demat account of the transferee, duly attested by the depository participant
  • f. Undertaking cum Indemnity as per a prescribed format (available on the company's website)
  • g. Such other documents as may be required on a case-to-case basis

Exclusions

Cases involving disputes between transferor and transferee (to be settled through court process) and shares that have been transferred to the Investor Education and Protection Fund (IEPF) are not eligible for processing under this special window.

Financial Impact

No specific financial impact is quantified in the disclosure. The announcement is procedural and administrative in nature, pertaining to share transfer regularization.